. Genetically targeted magnetic control of the nervous system. Nat Neurosci. 2016 Mar 7; PubMed.


Please login to recommend the paper.


  1. Molecular Magneto is a very interesting and exciting technique for laboratory research on calcium channels, GABAnergic neurons, and gene control. None of this is surprising to those who have been studying magnetic fields in the laboratory or clinically. Kevin Yarema at Johns Hopkins is using moderate magnetic fields in human stem cell lines, and my work in mouse models and clinic patients using 0.5 T DC EMF have been published previously. Wang et al. found that 2,500 genes were up- and downregulated after two to five days. I, along with Larry Pearce, presented clinical data on response to DC EMF in patients with Parkinson's and Alzheimer's disease at several Society of Neuroscience Annual Meetings in the last decade. I also published the effect of moderate magnetic fields on the mitochondria in mice and men. Martin Blank while at Columbia has patented picotesla electromagnetic field response elements into a gene promoter to serve as switches for regulating genes.

    What is troubling is that biophysical techniques have lagged behind due to prevailing funding of research. Hopefully this Molecular Magneto will not only open up neuronal channels, but help usher in magnetic and other biophysical therapies in the 21st century.

    See also:

    Nichols, Pearce et al. Clinical observations on magnetic molecular energizer on Alzheimer's and Parkinson's patients and their possible association with heavy metals

    Goodman, Lin, Blank. U.S. Patent 20020099026 A1.


    . Moderate strength (0.23-0.28 T) static magnetic fields (SMF) modulate signaling and differentiation in human embryonic cells. BMC Genomics. 2009;10:356. PubMed.

    . Mitochondria of mice and men: moderate magnetic fields in obesity and fatty liver. Med Hypotheses. 2012 Sep;79(3):287-93. Epub 2012 Jun 26 PubMed.

    View all comments by Trent Nichols

Make a Comment

To make a comment you must login or register.